International Patent: COMBINATION TREATMENTS USING EPIGENETIC INHIBITION AND SYNGRI-MEDIATED FRATAXIN EXPRESSION

GENEVA, June 19 -- ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. filed a patent application (US2025/055125) for “COMBINATION TREATMENTS USING EPIGENETIC INHIBITION AND SYNGRI-MEDIATED FRATAXIN EXPRESSION”. With publication no. WO/2026/107052, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/55

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....